Russia aims to produce ‘millions’ of virus doses by 2021

first_imgRussia said Monday it aims to launch mass production of a coronavirus vaccine next month and turn out “several million” doses per month by next year.The country is pushing ahead with several vaccine prototypes and one prepared at the Gamaleya institute in Moscow has reached advanced stages of development.”We are very much counting on starting mass production in September,” industry minister Denis Manturov said in an interview published by TASS news agency. Gamaleya’s vaccine employs the adenovirus, a similar technology to the coronavirus vaccine prototype developed by China’s CanSino, currently in the advanced stage of clinical trials.The Gamaleya institute came under fire after researchers and directors injected themselves with the prototype months ago, with specialists criticizing the move as an unorthodox and rushed way of starting human trials. Scientists have told AFP that Russia will struggle to adapt the vaccine to mass production because the country lacks raw materials, adequate facilities and experience, particularly with advanced technology like viral vector.Some Russian officials have boasted that the country will be the first to come up with the vaccine, even comparing it to the space race to produce the first satellite in the Soviet era.Moscow has dismissed allegations from the UK, the United States and Canada that a hacking group linked to Russian intelligence services tried to steal information about a coronavirus vaccine from labs in the West.Russia’s coronavirus caseload is currently fourth in the world after the United States, Brazil and India. “We will be able to ensure production volumes of several hundred thousand a month, with an eventual increase to several million by the start of next year,” he said, adding that one developer is preparing production technology at three locations in central Russia.Health Minister Mikhail Murashko on Saturday said the Gamaleya vaccine had “completed clinical trials” and that documents were being prepared to register it with the state.Another vaccine, developed by Siberia-based Vektor lab, is currently undergoing clinical trials and two more will begin human testing within the next two months, Murashko said.Gamaleya’s vaccine is a so-called viral vector vaccine, meaning it employs another virus to carry the DNA encoding of the needed immune response into cells.center_img Topics :last_img read more

It’s on us to make sure bravery of #MeToo victims is not wasted

first_img  SHARE  TWEET First Lady Frances Wolf,  It’s On Us PA,  Public Safety,  The Blog,  Women’s Rights Both Tom and I are heartbroken yet inspired by all the Americans and Pennsylvanians saying #MeToo this week. Sexual harassment and sexual violence are a black-eye of our society that we too often cover-up. This must change.Nearly two years ago Tom and I launched the first-ever state-level #ItsOnUs program to educate more Pennsylvanians about sexual assault and preventing it, especially on college campuses. Building off the momentum of the national It’s On Us movement, It’s On Us PA brings together college and university presidents, superintendents, administrators, teachers, students, families, and community members to help end sexual assault by standing up and speaking out.But our words aren’t enough to end sexual harassment and sexual violence. We must take action.This year, Tom announced a package of six pieces of legislation aimed at combating sexual violence. This bipartisan legislation is the result of students, parents, advocates, education leaders, and people across the commonwealth working together to improve reporting and response standards for sexual assault on K-12 and college campuses.Take the pledge. Call your legislators. We can’t let down all those speaking out who have been affected by sexual harassment and violence. It’s on all of us to make sure their bravery is not wasted. SHARE Email Facebook Twitter It’s on us to make sure bravery of #MeToo victims is not wasted October 18, 2017 Like Governor Tom Wolf on Facebook: Facebook.com/GovernorWolf By: First Lady Frances Wolflast_img read more

AJ backed for BBC Sports Personality of the Year

first_img StumbleUpon GVC hails SportsAid programme developing next generation of British athletes August 7, 2020 Share FSB selects Glenn Elliott as new COO August 12, 2020 Submit GVC absorbs retail shocks as business recalibrates for critical H2 trading August 13, 2020 Related Articles Share Anthony Joshua is the clear favourite to be crowned BBC Sports Personality of the Year, after the Watford boxer enjoyed a hugely successful year defeating Wladimir Klitschko to become the undisputed heavyweight champion of the World. Joshua went onto defend his crowns in Cardiff against tough challenger Carlos Takam, furthermore, AJ could be looking at an equally as triumphant 2018 with the fighter priced up at 4/6 to beat his newly returning domestic rival Tyson Fury. Nonetheless, although Joshua is clearly heading the BBC Sports Personality of the Year market, Mo Farah is the proving most popular pick with punters, according to Ladbrokes.AJ is as short as 1/7 for the BBC gong, while Lewis Hamilton is his nearest challenger at 7/1. Chris Froome has drifted from 10/1 to 33/1 this week, and that’s a price he shares with the most popular selection in the market in Farah.And the bookies can report that before the 12-strong shortlist was announced, Jermain Defoe was the most backed sports star in the field.Alex Apati of Ladbrokes said: “It’s hard to see past AJ after another stunning year in the ring, but at 33/1, plenty of punters reckon that if anyone is likely to cause an upset, it’ll be Farah.”Ladbrokes Latest BettingBBC Sports Personality of the YearAnthony Joshua – 1/7Lewis Hamilton – 7/1Mo Farah – 33/1Chris Froome – 33/1Harry Kane – 40/1Jonathan Rea – 50/1Adam Peaty – 66/1Jonnie Peacock – 66/1Anya Shrubsole – 100/1Johanna Konta – 100/1Bianca Walkden – 200/1Elise Christie – 200/1last_img read more